about
Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mappingShortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.Receptor tyrosine kinases: from biology to pathology.Pharmacogenomic considerations of xenograft mouse models of acute leukemia.Nucleoside analogs: ready to enter the era of precision medicine?Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Pharmacogenomics in acute myeloid leukemia.
@en
Pharmacogenomics in acute myeloid leukemia.
@nl
type
label
Pharmacogenomics in acute myeloid leukemia.
@en
Pharmacogenomics in acute myeloid leukemia.
@nl
prefLabel
Pharmacogenomics in acute myeloid leukemia.
@en
Pharmacogenomics in acute myeloid leukemia.
@nl
P2860
P356
P1433
P1476
Pharmacogenomics in acute myeloid leukemia
@en
P2093
Christophe Roumier
P2860
P304
P356
10.2217/PGS.09.130
P577
2009-11-01T00:00:00Z